CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 124 of 124 entries

View as:

Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma

Phase: N/A Priority: Normal

NCT ID: NCT04201756 Org: User:

Start: 07/26/20 End: 08/30/22 Due: 08/30/23

A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer

Phase: N/A Priority: Normal

NCT ID: NCT06620796 Org: User:

Start: 09/30/24 End: 09/30/27 Due: 09/30/28

Application of Three-Dimensionally Printed Navigational Template in Lung Biopsy

Phase: N/A Priority: Normal

NCT ID: NCT04775901 Org: User:

Start: 11/25/20 End: 12/31/23 Due: 12/31/24

A Multicenter Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal

NCT ID: NCT06530797 Org: User:

Start: 08/01/24 End: 09/01/26 Due: 09/01/27

Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection

Phase: N/A Priority: Normal

NCT ID: NCT05827328 Org: User:

Start: 01/29/23 End: 06/30/23 Due: 06/30/24

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial

Phase: N/A Priority: Normal

NCT ID: NCT05891080 Org: User:

Start: 07/01/23 End: 07/01/30 Due: 07/01/31

The Incidence and Risk Factors of Central Nervous System Adverse Events of Lorlatinib in Patients with ALK-positive Advanced Non-small Cell Lung Cancer: a Real-world Study

Phase: N/A Priority: Normal

NCT ID: NCT06652555 Org: User:

Start: 10/30/24 End: 09/29/27 Due: 09/29/28

Efficacy and Safety of An'Ningpai Expectorant in Non-CF Bronchiectasis

Phase: N/A Priority: Normal

NCT ID: NCT04511897 Org: User:

Start: 01/01/21 End: 06/30/23 Due: 06/30/24

The Efficacy and Safety of Ensartinib As Adjuvant Therapy in Stage I ALK-positive NSCLC Patients with High Risk Factors

Phase: N/A Priority: Normal

NCT ID: NCT06772610 Org: User:

Start: 03/15/25 End: 03/31/32 Due: 03/31/33

Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Phase: N/A Priority: Normal

NCT ID: NCT04985201 Org: User:

Start: 11/01/21 End: 08/01/23 Due: 08/01/24

Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical Study of Locally Advanced or Metastatic Non-small Cell Lung Cancer with HER2 Mutation/amplification/expression

Phase: N/A Priority: Normal

NCT ID: NCT06749860 Org: User:

Start: 02/02/24 End: 06/06/27 Due: 06/06/28

Assessment of an Exhaled Breath Test to Detect Bronchiectasis

Phase: N/A Priority: Normal

NCT ID: NCT05293314 Org: User:

Start: 07/01/22 End: 05/20/23 Due: 05/20/24

WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma

Phase: N/A Priority: Normal

NCT ID: NCT05925764 Org: User:

Start: 10/15/24 End: 12/31/24 Due: 12/31/25

Airway Clearance Technique of Oscillation and Lung Expansion in Bronchiectasis

Phase: N/A Priority: Normal

NCT ID: NCT06393257 Org: User:

Start: 09/01/23 End: 05/31/26 Due: 05/31/27

The Efficacy and Safety of KN046 Combined With Axitinib

Phase: N/A Priority: Normal

NCT ID: NCT06020352 Org: User:

Start: 08/25/23 End: 07/01/25 Due: 07/01/26

Augmented Reality Navigation Versus Traditional CT Guidance for Preoperative Localization of Pulmonary Nodules

Phase: N/A Priority: Normal

NCT ID: NCT06335563 Org: User:

Start: 03/14/24 End: 12/01/24 Due: 12/01/25

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Phase: N/A Priority: Normal

NCT ID: NCT04355806 Org: User:

Start: 06/01/20 End: 05/31/23 Due: 05/31/24

Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial

Phase: N/A Priority: Normal

NCT ID: NCT06620822 Org: User:

Start: 09/30/24 End: 09/30/27 Due: 09/30/28

Pilot Clinical Trial of PRS TB Regimen I - Phase II

Phase: N/A Priority: Normal

NCT ID: NCT03561753 Org: User:

Start: 12/01/17 End: 01/31/20 Due: 01/31/21

Corticosteroid Treatment for Acute Respiratory Distress Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT02819453 Org: User:

Start: 01/31/15 End: 12/31/17 Due: 12/31/18

Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis

Phase: N/A Priority: Normal

NCT ID: NCT02507843 Org: User:

Start: 01/31/15 End: 06/30/17 Due: 06/30/18

Bronchoscopic Microwave Intervention Treatment in Advanced Central NSCLC

Phase: N/A Priority: Normal

NCT ID: NCT04360655 Org: User:

Start: 05/01/20 End: 05/01/23 Due: 05/01/24

Toripalimab Combined With SBRT for NSCLC

Phase: N/A Priority: Normal

NCT ID: NCT06293690 Org: User:

Start: 03/15/24 End: 06/30/26 Due: 06/30/27

Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal

NCT ID: NCT06644313 Org: User:

Start: 11/01/24 End: 11/01/29 Due: 11/01/30

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma	NCT04201756	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2020-07-26	2022-08-30	2023-08-30	-	-	2025-07-14
A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer	NCT06620796	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2024-09-30	2027-09-30	2028-09-30	-	-	2025-07-14
Application of Three-Dimensionally Printed Navigational Template in Lung Biopsy	NCT04775901	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2020-11-25	2023-12-31	2024-12-31	-	-	2025-07-14
A Multicenter Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Lung Cancer	NCT06530797	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2024-08-01	2026-09-01	2027-09-01	-	-	2025-07-14
Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection	NCT05827328	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2023-01-29	2023-06-30	2024-06-30	-	-	2025-07-14
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial	NCT05891080	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2023-07-01	2030-07-01	2031-07-01	-	-	2025-07-14
The Incidence and Risk Factors of Central Nervous System Adverse Events of Lorlatinib in Patients with ALK-positive Advanced Non-small Cell Lung Cancer: a Real-world Study	NCT06652555	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2024-10-30	2027-09-29	2028-09-29	-	-	2025-07-14
Efficacy and Safety of An'Ningpai Expectorant in Non-CF Bronchiectasis	NCT04511897	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2021-01-01	2023-06-30	2024-06-30	-	-	2025-07-14
The Efficacy and Safety of Ensartinib As Adjuvant Therapy in Stage I ALK-positive NSCLC Patients with High Risk Factors	NCT06772610	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2025-03-15	2032-03-31	2033-03-31	-	-	2025-07-14
Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy	NCT04985201	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2021-11-01	2023-08-01	2024-08-01	-	-	2025-07-14
Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical Study of Locally Advanced or Metastatic Non-small Cell Lung Cancer with HER2 Mutation/amplification/expression	NCT06749860	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2024-02-02	2027-06-06	2028-06-06	-	-	2025-07-14
Assessment of an Exhaled Breath Test to Detect Bronchiectasis	NCT05293314	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2022-07-01	2023-05-20	2024-05-20	-	-	2025-07-14
WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma	NCT05925764	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2024-10-15	2024-12-31	2025-12-31	-	-	2025-07-14
Airway Clearance Technique of Oscillation and Lung Expansion in Bronchiectasis	NCT06393257	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2023-09-01	2026-05-31	2027-05-31	-	-	2025-07-14
The Efficacy and Safety of KN046 Combined With Axitinib	NCT06020352	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2023-08-25	2025-07-01	2026-07-01	-	-	2025-07-14
Augmented Reality Navigation Versus Traditional CT Guidance for Preoperative Localization of Pulmonary Nodules	NCT06335563	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2024-03-14	2024-12-01	2025-12-01	-	-	2025-07-14
Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors	NCT04355806	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2020-06-01	2023-05-31	2024-05-31	-	-	2025-07-14
Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial	NCT06620822	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2024-09-30	2027-09-30	2028-09-30	-	-	2025-07-14
Pilot Clinical Trial of PRS TB Regimen I - Phase II	NCT03561753	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2017-12-01	2020-01-31	2021-01-31	-	-	2025-07-14
Corticosteroid Treatment for Acute Respiratory Distress Syndrome	NCT02819453	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2015-01-31	2017-12-31	2018-12-31	-	-	2025-07-14
Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis	NCT02507843	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2015-01-31	2017-06-30	2018-06-30	-	-	2025-07-14
Bronchoscopic Microwave Intervention Treatment in Advanced Central NSCLC	NCT04360655	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2020-05-01	2023-05-01	2024-05-01	-	-	2025-07-14
Toripalimab Combined With SBRT for NSCLC	NCT06293690	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2024-03-15	2026-06-30	2027-06-30	-	-	2025-07-14
Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)	NCT06644313	Shanghai Pulmonary Hospital, Shanghai, China	user2@example.com	None	2024-11-01	2029-11-01	2030-11-01	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance